Risk of Falls with Benzodiazepine Receptor Agonists in Combination with Novel hypnotics.

Yuya Higuchi, Yuya Ishikawa, Ph.D, Takuya Araki, Ph.D, Yukina Ohshima, Ph.D, Hideaki Yashima, Ph.D., Koujirou Yamamoto, Ph.D.

Abstract

Several risk factors for falls during hospitalization have been reported, of which hypnotics have a major influence. Insomnia is often intractable, and many cases are treated with two or more hypnotics; however, there is concern about the increased risk of falls due to the use of multiple hypnotics. Therefore, we aimed to clarify the effects of combining conventional and new hypnotics on the risk of falls. The impact of the concomitant use of hypnotics on the occurrence of fall events was evaluated retrospectively in patients 20 years of age and older received acute care medicine in a university hospital between January 2013 and August 2022. The survey items included age, sex, drug prescription status, whether a fall accident had occurred, and its circumstances. Of the 47,236 eligible patients, 976 experienced a fall accident during hospitalization (fall rate, 2.07%). Logistic regression analysis of the patient population not taking benzodiazepine receptor agonists showed that age (odds ratio [OR], 1.04), sex (OR, 0.84), and ramelteon use (OR, 3.06) independently contributed to falls. In contrast, in the patient population taking benzodiazepine receptor agonists, logistic regression analysis showed that only age (OR: 1.03) and sex (OR: 0.76) independently contributed to falls. This suggests that ramelteon, suvorexant, and lemborexant, in combination with benzodiazepines, may not increase the risk of falls. Hypnotics with novel mechanisms of action may not increase the risk of fall when combined with benzodiazepine receptor agonists. evaluasi.

 

Keywords: fall risk, hypnotics, acute care hospitals

Full Text:

PDF HTML

References

Moreland B, Kakara R, Henry A. Trends in Nonfatal Falls and Fall-Related Injuries Among Adults Aged ≥65 Years - United States, 2012-2018. MMWR Morb Mortal Wkly Rep. 2020;69:875–81.

Court-Brown CM, Clement ND, Duckworth AD, Biant LC, McQueen MM. The changing epidemiology of fallrelated fractures in adults. Injury. 2017;48:819–24.

LeLaurin JH, Shorr RI. Preventing Falls in Hospitalized Patients: State of the Science. Clin Geriatr Med. 2019;35:273– 83.

Gammel LB, Leonard M, Wheeler H, Linh H, Burns B Jr. Controlled Substance Use and Clinical Outcomes of Elderly Patients After a Fall. Cureus. 2022;14:e22356.

Nielsen S. Benzodiazepines. Curr Top Behav Neurosci. 2017;34:141–59.

Woolcott JC, Richardson KJ, Wiens MO, Patel B, Marin J, Khan KM, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med. 2009;169:1952–60.

Buth S, Holzbach R, Martens MS, Neumann-Runde E, Meiners O, Verthein U. Problematic Medication With Benzodiazepines, “Z-drugs”, and Opioid Analgesics. Dtsch Arztebl Int. 2019;116:607–14.

Valencia Morales DJ, Laporta ML, Johnson RL, Schroeder DR, Sprung J, Weingarten TN. A Case-Control Study of Accidental Falls During Surgical Hospitalizations. Am Surg. 2023;89:61–8.

Seppala LJ, Wermelink AMAT, de Vries M, Ploegmakers KJ, van de Glind EMM, Daams JG, et al. Fall-RiskIncreasing Drugs: A Systematic Review and Meta-Analysis: II. Psychotropics. J Am Med Dir Assoc. 2018;19:371.e11- 371.e17.

Obayashi K, Araki T, Nakamura K, Kurabayashi M, Nojima Y, Hara K, et al. Risk of falling and hypnotic drugs: retrospective study of inpatients. Drugs R D. 2013;13:159–64.

Ishibashi Y, Nishitani R, Shimura A, Takeuchi A, Touko M, Kato T, et al. Non-GABA sleep medications, suvorexant as risk factors for falls: Casecontrol and case-crossover study. PLoS One. 2020;15:e0238723.

Torii H, Ando M, Tomita H, Kobaru T, Tanaka M, Fujimoto K, et al. Association of Hypnotic Drug Use with Fall Incidents in Hospitalized Elderly Patients: A Case-Crossover Study. Biol Pharm Bull. 2020;43:925–31.

Hashida R, Matsuse H, Yokoyama S, Kawano S, Higashi E, Tajma H, et al. Balance dysfunction the most significant cause of in-hospital falls in patients taking hypnotic drugs: A retrospective study. PLoS One. 2022;17:e0272832.

Sogawa R, Emoto A, Monji A, Miyamoto Y, Yukawa M, MurakawaHirachi T, et al. Association of orexin receptor antagonists with falls during hospitalization. J Clin Pharm Ther. 2022;47:809–13.

Masakazu H, Hiroyuki K, Risa I , Haruna M, Manako H , Shigeki Y, et al. Assessment of Switching to Suvorexant versus the Use of Add-on Suvorexant in Combination with Benzodiazepine Receptor Agonists in Insomnia Patients: A Retrospective Study. Clin Psychopharmacol Neurosci. 2018 May 31;16(2):184-189.

Mj G. Falls in later life. Improving the Health of Older People A World View. 1990:296–315.

Noh H-M, Song HJ, Park YS, Han J, Roh YK. Fall predictors beyond fall risk assessment tool items for acute hospitalized older adults: a matched casecontrol study. Sci Rep. 2021;11:1503.

Franco C, Gian D, Edoardo O , Marco C , Valeria F, Norio W, et al. Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis. Lancet. 2022 Jul 16;400(10347):170-184

DOI: https://doi.org/10.24198/idjp.v5i1.41451

Refbacks

  • There are currently no refbacks.